NASDAQ: KRYS · Health Care / Biotechnology: Biological Products (No Diagnostic Substances)

Krystal Biotech Inc.

How Krystal Biotech Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$9.6B

Price

$324.55

P/E

39.8

EPS (TTM)

$8.16

1-year return

75.4%

Dividend yield

0.0%

52-week range

$204.22–$332.56

Compared with

• Biotechnology: Biological Products (No Diagnostic Substances) industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources